# Biomarker Development for Muscular Dystrophies

> **NCT05019625** · — · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 465 (estimated)

## Conditions studied

- Myotonic Dystrophy
- Duchenne Muscular Dystrophy
- Becker Muscular Dystrophy
- Facioscapulohumeral Muscular Dystrophy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05019625
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2015-02-20
- **Primary completion:** 2027-06
- **Final completion:** 2028-06
- **Target enrollment:** 465 (ESTIMATED)
- **Last updated:** 2025-11-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05019625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05019625, "Biomarker Development for Muscular Dystrophies". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05019625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*